GHP Investment Advisors Inc. Purchases 928 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

GHP Investment Advisors Inc. raised its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.1% in the second quarter, Holdings Channel reports. The fund owned 86,540 shares of the company’s stock after buying an additional 928 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Prestige Consumer Healthcare were worth $5,958,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently bought and sold shares of the company. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare during the second quarter valued at about $26,000. Principal Securities Inc. bought a new stake in Prestige Consumer Healthcare during the fourth quarter valued at about $29,000. Quest Partners LLC boosted its holdings in Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after acquiring an additional 424 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Prestige Consumer Healthcare by 80.6% during the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after acquiring an additional 208 shares during the period. Finally, Gladius Capital Management LP bought a new stake in Prestige Consumer Healthcare during the second quarter valued at about $35,000. 99.95% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on PBH. DA Davidson upped their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $80.00 price objective on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. Finally, StockNews.com lowered shares of Prestige Consumer Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, May 21st. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $98.75.

Prestige Consumer Healthcare Stock Up 1.7 %

Shares of PBH opened at $74.12 on Friday. The company has a 50-day simple moving average of $70.77 and a 200-day simple moving average of $69.56. The firm has a market capitalization of $3.67 billion, a P/E ratio of 17.77, a P/E/G ratio of 2.01 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.90 and a current ratio of 3.23. Prestige Consumer Healthcare Inc. has a 52 week low of $56.34 and a 52 week high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The firm had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company’s revenue for the quarter was down 4.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.06 earnings per share. On average, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.